These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 17339550

  • 1. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk.
    Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K, ONTARGET/TRANSCEND Investigators.
    Circulation; 2007 Mar 20; 115(11):1371-5. PubMed ID: 17339550
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials.
    Teo K, Yusuf S, Sleight P, Anderson C, Mookadam F, Ramos B, Hilbrich L, Pogue J, Schumacher H, ONTARGET/TRANSCEND Investigators.
    Am Heart J; 2004 Jul 20; 148(1):52-61. PubMed ID: 15215792
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.
    Cukierman-Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, Jackson SH, Yusuf S, Teo K, ONTARGET/TRANSCEND Investigators.
    Diabetes Res Clin Pract; 2009 Mar 20; 83(3):387-93. PubMed ID: 19157618
    [Abstract] [Full Text] [Related]

  • 10. The ONTARGET/TRANSCEND Trial Programme: baseline data.
    Sleight P.
    Acta Diabetol; 2005 Apr 20; 42 Suppl 1():S50-6. PubMed ID: 15868120
    [Abstract] [Full Text] [Related]

  • 11. Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data.
    Yu LT, Zhu J, Tan HQ, Wang GG, Teo KK, Liu LS.
    Chin Med J (Engl); 2011 Jun 20; 124(12):1763-8. PubMed ID: 21740829
    [Abstract] [Full Text] [Related]

  • 12. Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]).
    Cowan BR, Young AA, Anderson C, Doughty RN, Krittayaphong R, Lonn E, Marwick TH, Reid CM, Sanderson JE, Schmieder RE, Teo K, Wadham AK, Worthley SG, Yu CM, Yusuf S, Jennings GL, ONTARGET Investigators.
    Am J Cardiol; 2009 Dec 01; 104(11):1484-9. PubMed ID: 19932779
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
    Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, Commerford P, Dyal L, Schumacher H, Pogue J, Paolasso E, Holwerda N, Chazova I, Binbrek A, Young J, Yusuf S, ONTARGET and TRANSCEND Investigators.
    Lancet Neurol; 2011 Jan 01; 10(1):43-53. PubMed ID: 20980201
    [Abstract] [Full Text] [Related]

  • 14. The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.
    Unger T.
    Am J Cardiol; 2003 May 22; 91(10A):28G-34G. PubMed ID: 12781906
    [Abstract] [Full Text] [Related]

  • 15. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF.
    Eur J Prev Cardiol; 2014 Mar 22; 21(3):299-309. PubMed ID: 24191305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.
    Barzilay JI, Kronmal RA, Gottdiener JS, Smith NL, Burke GL, Tracy R, Savage PJ, Carlson M.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2236-41. PubMed ID: 15193686
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.